Literature DB >> 3135314

Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A.

P A Kiener1, F Marek, G Rodgers, P F Lin, G Warr, J Desiderio.   

Abstract

The effect of the i.v. administration of endotoxin (LPS), diphosphoryl lipid A, and the non-toxic derivative monophosphoryl lipid A (MPL), on the production of serum cachectin (TNF), IFN-gamma, and the appearance of endotoxin shock have been measured in mice primed with Listeria monocytogenes. All three of the lipid A varieties induced the production of TNF in a dose-dependent manner. Although comparable peak levels of TNF were produced (5 X 10(5) to 1 X 10(6) U/ml), treatments with LPS or diphosphoryl lipid A were lethal whereas those with MPL were not. A study following TNF in the mouse sera for up to 24 h after treatment with the lipid A types showed that serum levels of TNF peaked 90 min after the treatment, and that TNF levels induced by LPS treatment were maintained for several hours longer than those induced by lipid A or MPL. All three molecules also resulted in the production of IFN-gamma in the serum, which peaked at 4 to 5 h after treatment. After 90 min there were no significant differences in the levels of serum IFN-gamma in any of the groups of treated animals. However, as was observed with the TNF, the levels of IFN in animals treated with LPS persisted longer than those induced by MPL or lipid A. These results suggest that the non-toxic MPL as well as the toxic forms of lipid A can induce the production of TNF by macrophages. Furthermore, although it is essential, TNF alone is not necessarily sufficient to induce septic shock in mice.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135314

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment.

Authors:  G J Zlabinger; K M Stuhlmeier; R Eher; S Schmaldienst; R Klauser; A Vychytil; B Watschinger; O Traindl; J Kovarik; E Pohanka
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

2.  Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity.

Authors:  P A van de Wiel; A van der Pijl; N Bloksma
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.

Authors:  F D Pagani; L S Baker; C Hsi; M Knox; M P Fink; M S Visner
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A.

Authors:  J Dijkstra; J W Mellors; J L Ryan
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

5.  Protection of mice against Listeria monocytogenes infection by recombinant human tumor necrosis factor alpha.

Authors:  J V Desiderio; P A Kiener; P F Lin; G A Warr
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

6.  Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice.

Authors:  A K Myers; J W Robey; R M Price
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

Review 7.  Evaluation of TNF as antiviral, antibacterial and antiparasitic agent.

Authors:  G A Rook; J Taverne; J H Playfair
Journal:  Biotherapy       Date:  1991

8.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  Actinomycin D upregulates lipopolysaccharide induction of macrophage procoagulant expression and tumour necrosis factor-alpha production.

Authors:  H R Wheeler; E J Rockett; I Clark; C L Geczy
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

10.  Differential effects of monoclonal antibodies to tumor necrosis factor alpha and gamma interferon on induction of hepatic nitric oxide synthase in experimental gram-negative sepsis.

Authors:  T Evans; A Carpenter; A Silva; J Cohen
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.